⌘K

Login Start Free

Home/Insiders/Javitt Daniel C.

JD

SEC Insider//CIK 0001864534

Javitt Daniel C.

CIK 00018645341 companyWILMINGTON, DE

Transactions

13

Companies

1

Filings

8

CIK

0001864534

Recent Transactions

13 trades

Sale
NRX Pharmaceuticals, Inc.$NRXP
common stock
2022-11-30$1.50/sh−8,441→ 9,634,793 total
Sale
NRX Pharmaceuticals, Inc.$NRXP
common stock
2022-11-29$1.50/sh−13,730→ 9,643,234 total
Sale
NRX Pharmaceuticals, Inc.$NRXP
common stock
2022-11-17$1.05/sh−33,018→ 9,656,964 total
Sale
NRX Pharmaceuticals, Inc.$NRXP
common stock
2022-11-16$1.02/sh−133,719→ 9,689,982 total
Sale
NRX Pharmaceuticals, Inc.$NRXP
common stock
2022-11-11$1.01/sh−49,200→ 9,823,701 total
Sale
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2022-07-29$1.01/sh−784,063→ 9,872,901 total
Gift
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2022-07-01−2,000,000→ 10,656,964 total
Sale
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2022-06-07$0.65/sh−86,459→ 12,656,964 total
Sale
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2022-06-06$0.67/sh−115,657→ 12,743,423 total
Sale
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2022-06-03$0.70/sh−243,596→ 12,859,080 total
Gift
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2021-07-16−434,594→ 13,537,270 total
Gift
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2021-07-16−434,594→ 13,102,676 total
Award
NRX Pharmaceuticals, Inc.$NRXP
Common Stock
2021-05-24+13,971,864→ 13,971,864 total

Companies

1

NRX Pharmaceuticals, Inc.
10% Owner
$NRXP

Recent Filings

8

Address

C/O NRX PHARMACEUTICALS, INC. 1201 ORANGE STREET, SUITE 600

WILMINGTON, DE, 19801

View on SEC.gov